| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
2,374.50
|
|
Change (%)
|
-24.35 (-1.02%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
2,358.00
-
2,401.25
|
|
52-Week Range (RS)
|
1,924.30
-
3,515.95
|
|
Beta (1 Year)
|
0.80
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap |
| News |
|
Corporate Details |
| GlaxoSmithKline Pharmaceuticals to table results |
| Indices tumble in early trade; breadth weak |
| Glaxosmithkline Pharmaceuticals consolidated net profit rises 1.98% in the September 2025 quarter |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Press Release |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Outcome of Board Meeting |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Investor Presentation |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Outcome of Board Meeting |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con... |
| GlaxoSmithKline Pharmaceuticals schedules board meeting |
| Glaxosmithkline Pharmaceuticals Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 |
|
|
|
| Incoporation Year : 1924 |
| Chairman : Renu S Karnad |
| Ownership Group : MNC Asc-Glaxo |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Glaxosmithkline Pharmaceuticals Ltd
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030 |
Phone:91-022-24959595
Fax:91-022-24959494 |
| E-Mail : askus@gsk.com; ajay.a.nadkarni@gsk.com |
| URL : http://www.gsk-india.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
01-Jan-2026 |
2455.25 |
-2.30 |
| 1Month |
08-Dec-2025 |
2543.40 |
-5.68 |
| 3Month |
08-Oct-2025 |
2727.80 |
-12.06 |
| 6Month |
08-Jul-2025 |
3259.30 |
-26.40 |
| 1Year |
08-Jan-2025 |
2207.85 |
8.65 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Midcap Fund |
1.27 |
296.83 |
| Kotak Large & Midcap Fund |
0.91 |
272.10 |
| Nippon India Pharma Fund |
2.73 |
225.90 |
| Nippon India Growth Mid Cap Fund |
0.33 |
138.27 |
| SBI Dividend Yield Fund |
1.22 |
111.31 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
28,042.90 |
-1.03 |
35,921.55 |
25,260.20 |
59,591.16 |
| Pfizer Ltd |
4,871.75 |
1.35 |
5,987.65 |
3,742.90 |
22,287.15 |
| Astrazeneca Pharma India Ltd |
8,327.35 |
-0.97 |
10,653.05 |
6,501.60 |
20,818.38 |
| Sanofi Consumer Healthcare India Ltd |
4,379.90 |
-0.07 |
5,954.00 |
4,285.00 |
10,087.18 |
| Sanofi India Ltd |
4,123.85 |
-0.79 |
6,717.50 |
4,050.00 |
9,497.23 |
|
|
|
|